AFP Measurement in Monitoring Treatment Response of Advanced Hepatocellular Carcinoma to Sorafenib: Case Report and Review of the Literature

Publisher： Karger

E-ISSN： 2296-5262|34|10|538-542

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.34, Iss.10, 2011-09, pp. : 538-542

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complete Response of Advanced Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Sorafenib: A Case Report

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 152-157

Karger

Access to resources Recommend Favorite

Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 82, Iss. 2, 2012-02 ,pp. : 119-125

Karger

Access to resources Recommend Favorite

Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 85-92

Karger

Access to resources Recommend Favorite

Diarrhea Is a Positive Outcome Predictor for Sorafenib Treatment of Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 84, Iss. 1, 2012-10 ,pp. : 6-13

Karger

Access to resources Recommend Favorite

Sorafenib in Elderly Patients with Advanced Hepatocellular Carcinoma: A Case Series

By  

Oncology, Vol. 84, Iss. 5, 2013-02 ,pp. : 265-272

Karger

Access to resources Recommend Favorite